Also listed on Prisma Health - Upstate, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Sep 9, 2037 · High confidence
20-year base term ends Jan 17, 2037
Held by Tao Life Sciences Inc.
Filed Jul 13, 2018 as application 16/070,263 · Granted Apr 20, 2021
Base term plus 235 days of patent term adjustment (USPTO delay)
Today
2017
2037
Clock starts
Jan 17, 2017
Jan 17, 2017
Term ends
Sep 9, 2037
Sep 9, 2037
Granted
Apr 20, 2021
Apr 20, 2021
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
235
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 235 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 17, 2017, when application PCT/US2017/013767, the earliest non-provisional in its chain, was filed (this one was filed Jul 13, 2018) | Jan 17, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +235 days, USPTO patent term adjustment record | Sep 9, 2037 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 9, 2037 | High confidence |
Partial family
| Application PCT/US2017/013767 | PCT application no patent term | no patent term |
| US 10,980,696 | this patent Sep 2037 | Sep 2037 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 5, 2019 Reel 48808, frame 875 | Dubose, Elizabeth | Prisma Health-Upstate | Assignment of Assignor's Interest |
| Apr 9, 2019 Reel 48835, frame 106 | Dickie, Robert | Tao Life Sciences Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2037
Term ends Sep 9, 2037. Maintenance fees still fall due before then
Note
The 235 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.